-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Cube Info
On May 5, Hengrui issued an announcement that according to the needs of business development, Mr.
This is the latest development of the adjustment of Hengrui Pharmaceutical's executive team this year
Dai Hongbin, male, born in 1976
Dai Hongbin's professional experience is quite stable.
At the business level, Dai Hongbin has been responsible for the company's securities, legal affairs, public relations, drug price management and market access for a long time, and has been participating in the national medical insurance negotiation on behalf of Hengrui Medicine and has achieved positive results.
After the general manager took office, the division of labor of the main senior management team of Hengrui Medicine has not changed much: Zhang Lianshan, deputy general manager of Hengrui Medicine and president of global R&D, is still in the field of innovative drug research and development.